Back to today’s briefing

Story perspectives

New Mutation May Delay Alzheimer’s, Boost Brain Resilience

6/24/2025

44 5

Summary

Story summary

A groundbreaking discovery by researchers at Weill Cornell Medicine reveals that the "Christchurch mutation," APOE3-R136S, may hold the key to delaying Alzheimer’s disease. By blocking the cGAS-STING pathway, this mutation reduces brain inflammation, paving the way for innovative treatments that could bolster brain resilience against neurodegenerative disorders like Alzheimer’s.

1 of 1

Story summary

A groundbreaking discovery by researchers at Weill Cornell Medicine reveals that the "Christchurch mutation," APOE3-R136S, may hold the key to delaying Alzheimer’s disease. By blocking the cGAS-STING pathway, this mutation reduces brain inflammation, paving the way for innovative treatments that could bolster brain resilience against neurodegenerative disorders like Alzheimer’s.